Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 41

Related Articles by Review for PubMed (Select 11694667)

1.

Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study.

Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR, Spencer T; Atomoxetine ADHD Study Group.

Pediatrics. 2001 Nov;108(5):E83.

PMID:
11694667
2.

[Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents].

Purper-Ouakil D, Fourneret P, Wohl M, Rénéric JP.

Encephale. 2005 May-Jun;31(3):337-48. Review. French.

PMID:
16142049
3.

Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

Paediatr Drugs. 2009;11(3):203-26. doi: 10.2165/00148581-200911030-00005. Review.

PMID:
19445548
4.

Atomoxetine, a novel treatment for attention-deficit-hyperactivity disorder.

Christman AK, Fermo JD, Markowitz JS.

Pharmacotherapy. 2004 Aug;24(8):1020-36. Review.

PMID:
15338851
5.

Atomoxetine.

Simpson D, Perry CM.

Paediatr Drugs. 2003;5(6):407-15; discussion 416-7. Review. Erratum in: Paediatr Drugs. 2003;5(10):661. Dosage error in article text.

PMID:
12765489
6.

A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R.

Health Technol Assess. 2006 Jul;10(23):iii-iv, xiii-146. Review.

8.

Atomoxetine: the first nonstimulant for the management of attention-deficit/hyperactivity disorder.

Corman SL, Fedutes BA, Culley CM.

Am J Health Syst Pharm. 2004 Nov 15;61(22):2391-9. Review.

PMID:
15581262
9.

Spotlight on atomoxetine in adults with attention-deficit hyperactivity disorder.

Simpson D, Plosker GL.

CNS Drugs. 2004;18(6):397-401. Review.

PMID:
15089111
10.

Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder.

Simpson D, Plosker GL.

Drugs. 2004;64(2):205-22. Review.

PMID:
14717619
11.

Update on atomoxetine in the treatment of attention-deficit/hyperactivity disorder.

Vaughan B, Fegert J, Kratochvil CJ.

Expert Opin Pharmacother. 2009 Mar;10(4):669-76. doi: 10.1517/14656560902762873 . Review.

PMID:
19239401
12.
13.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
14.

Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.

Findling RL.

Clin Ther. 2008 May;30(5):942-57. doi: 10.1016/j.clinthera.2008.05.006. Review.

PMID:
18555941
15.

Use of atomoxetine in patients with attention-deficit hyperactivity disorder and co-morbid conditions.

Dell'Agnello G, Zuddas A, Masi G, Curatolo P, Besana D, Rossi A.

CNS Drugs. 2009 Sep;23(9):739-53. doi: 10.2165/11314350-000000000-00000. Review.

PMID:
19689165
16.

Assessing the value of atomoxetine in treating children and adolescents with ADHD in the UK.

Prasad S, Arellano J, Steer C, Libretto SE.

Int J Clin Pract. 2009 Jul;63(7):1031-40. doi: 10.1111/j.1742-1241.2009.02090.x. Review.

PMID:
19570121
17.

Spotlight on atomoxetine in attention-deficit hyperactivity disorder in children and adolescents.

Garnock-Jones KP, Keating GM.

CNS Drugs. 2010 Jan;24(1):85-8. doi: 10.2165/11203670-000000000-00000. Review.

PMID:
20030421
18.

Guanfacine extended-release: in attention deficit hyperactivity disorder.

Muir VJ, Perry CM.

Drugs. 2010 Sep 10;70(13):1693-702. doi: 10.2165/11205940-000000000-00000. Review.

PMID:
20731476
19.

Atomoxetine for treating ADHD symptoms in autism: a systematic review.

Ghanizadeh A.

J Atten Disord. 2013 Nov;17(8):635-40. doi: 10.1177/1087054712443154. Epub 2012 Apr 27. Review.

PMID:
22544388
20.

Pharmacotherapy of attention-deficit hyperactivity disorder in adolescents.

Childress AC, Berry SA.

Drugs. 2012 Feb 12;72(3):309-25. doi: 10.2165/11599580-000000000-00000. Review.

PMID:
22316347
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk